Director Ronda E. Stryker filed a Form 4 with the SEC on November 9, 2026, disclosing the sale of 549,000 shares of Stryker Corp (NYSE:SYK) common stock on November 6, 2026, through a revocable trust at weighted average prices ranging from $323.189 to $327.685 per share.
Key Highlights
- Reporting person: Ronda E. Stryker, identified in the filing as a Director of Stryker Corp
- Total shares sold: Six separate sale transactions on November 6, 2026, covering 33,466, 131,707, 142,794, 149,357, 82,089, and 10,587 shares, respectively, all disposed of indirectly through a revocable trust
- Weighted average prices: The six tranches carried weighted average prices of $323.189, $324.091, $325.109, $325.967, $327.03, and $327.685 per share
- Post-transaction holdings via revocable trust: Following all six sales, the reporting person beneficially owned 1,701,375 shares indirectly through the revocable trust
- Additional indirect holdings: The filing also reports 12,177,521 shares held indirectly by L. Lee Stryker Trust and 37,600 shares held indirectly by the 1988 William D. Johnston Trust, plus 762 shares held directly
- Transaction codes: All six transactions are coded "S" (open-market sale) in the filing
Six-Tranche Sale of Stryker Corp Common Stock by Director Ronda E. Stryker
According to the Form 4 filed on November 9, 2026, Ronda E. Stryker, a director of Stryker Corp, disposed of shares of the company's common stock across six separate tranches on November 6, 2026. All sales were executed indirectly through a revocable trust. The filing notes that each price reported is a weighted average, and the actual per-share prices within each tranche spanned a defined range. For example, the first tranche of 33,466 shares was sold at prices ranging from $322.56 to $323.555, inclusive, with a weighted average of $323.189. The sixth and final tranche of 10,587 shares was sold at prices from $327.56 to $328.01, with a weighted average of $327.685.
The filing states that the reporting person undertakes to provide full information regarding the number of shares sold at each separate price within any given range, upon request by SEC staff, the issuer, or any security holder. Stryker Corp is a Michigan-based medical technology company whose common stock trades on the New York Stock Exchange under the ticker SYK. After the six reported sales, the revocable trust's beneficial ownership stood at 1,701,375 shares, according to the filing. The filing additionally discloses that the reporting person holds 12,177,521 shares indirectly through the L. Lee Stryker Trust, 37,600 shares indirectly through the 1988 William D. Johnston Trust, and 762 shares directly.
The Form 4 was signed by Austin Y. Ke as attorney-in-fact for Ronda E. Stryker and dated November 9, 2026. No derivative securities transactions were reported in Table II of the filing.
What Was Disclosed
The filing reports six open-market sales of Stryker Corp common stock by Director Ronda E. Stryker on November 6, 2026, all executed indirectly through a revocable trust at weighted average prices between $323.189 and $327.685 per share, with total post-sale beneficial ownership across all accounts exceeding 13.9 million shares.




Please wait processing your request...